Fmr LLC Boosts Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

FMR LLC boosted its holdings in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 22.8% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 86,464 shares of the company's stock after buying an additional 16,040 shares during the quarter. FMR LLC owned approximately 0.48% of Addus HomeCare worth $11,502,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. UMB Bank n.a. grew its position in Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company's stock worth $26,000 after acquiring an additional 88 shares during the last quarter. Quest Partners LLC acquired a new stake in shares of Addus HomeCare during the second quarter valued at about $31,000. Farther Finance Advisors LLC grew its holdings in shares of Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock worth $49,000 after purchasing an additional 366 shares during the last quarter. Innealta Capital LLC acquired a new position in shares of Addus HomeCare in the second quarter valued at approximately $44,000. Finally, Sandia Investment Management LP bought a new position in Addus HomeCare in the 2nd quarter valued at approximately $58,000. Institutional investors own 95.35% of the company's stock.

Wall Street Analysts Forecast Growth

ADUS has been the topic of a number of research reports. StockNews.com raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Wednesday. Stephens increased their price objective on Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a report on Wednesday, November 6th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. Macquarie reissued an "outperform" rating and issued a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. Finally, KeyCorp started coverage on Addus HomeCare in a report on Friday, October 11th. They issued an "overweight" rating and a $150.00 target price on the stock. One analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Addus HomeCare currently has an average rating of "Moderate Buy" and an average target price of $131.63.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock traded up $1.10 on Thursday, reaching $122.00. 137,707 shares of the company's stock were exchanged, compared to its average volume of 130,392. The company has a market capitalization of $2.21 billion, a P/E ratio of 27.67, a price-to-earnings-growth ratio of 2.11 and a beta of 1.02. Addus HomeCare Co. has a 52 week low of $85.94 and a 52 week high of $136.12. The firm's 50-day moving average is $125.76 and its two-hundred day moving average is $124.29.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. During the same period in the prior year, the firm earned $1.03 earnings per share. Addus HomeCare's revenue was up 7.1% on a year-over-year basis. On average, analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Insider Activity

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the firm's stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares of the company's stock, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares of the company's stock, valued at $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by company insiders.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.